MedPath

Efficacy and Safety of Diclofenac Sodium Gel in Hand Osteoarthritis

Phase 3
Completed
Conditions
Osteoarthritis
Registration Number
NCT00171652
Lead Sponsor
Novartis
Brief Summary

This study will test the efficacy and safety of topical diclofenac sodium gel in the treatment of hand osteoarthritis.

Detailed Description

Not available

Recruitment & Eligibility

Status
COMPLETED
Sex
All
Target Recruitment
360
Inclusion Criteria

Not provided

Exclusion Criteria
  • Other rheumatic disease, such as rheumatoid arthritis
  • Active gastrointestinal ulcer during the last year
  • Known allergy to analgesic drugs

Study & Design

Study Type
INTERVENTIONAL
Study Design
PARALLEL
Primary Outcome Measures
NameTimeMethod
OA pain intensity in target hand at Week 4 and 6
Total AUSCAN score in target hand at Week 4 and 6
Global rating of disease activity by patient at Week 4 and 6
Secondary Outcome Measures
NameTimeMethod
Global evaluation of treatment at final visit
OA pain intensity and total AUSCAN score in target hand, and global rating of disease activity by patient at Weeks 1, 2 and 8
AUSCAN pain, stiffness and physical function scores in target hand, and global rating of benefit by patient at Weeks 1, 2, 4, 6 and 8
Treatment responder rate according to OARSI criteria
OA pain intensity in target hand and use of rescue medication recorded in diary
© Copyright 2025. All Rights Reserved by MedPath